NovaMechanicsChemoinformatics & Bioinformatics Solutions
Publications

 

·        


Melagraki Georgia*; Afantitis Antreas* A Risk Assessment Tool for the Virtual Screening of Metal Oxide Nanoparticles through Enalos InSilicoNano Platform Current Topics in Medicinal Chemistry, Volume 15, Number 18, September 2015, pp. 1827-1836(10) 2015 (link)

Antreas Afantitis*, Georgia Melagraki* Editorial (Thematic Issue: Advances in Cheminformatics: Drug Discovery, Computational Toxicology and Nanomaterials (Part II)) Combinatorial Chemistry & High Throughput Screening, Volume 18, Number 4, May 2015, pp. 333-334(2) 2015 (link)

Georgia Melagraki*, Antreas Afantitis* Editorial (Thematic Issue: Advances in Cheminformatics: Drug Discovery, Computational Toxicology and Nanomaterials (Part I) Combinatorial Chemistry & High Throughput Screening, Volume 18, Number 3, January 2015, pp. 236-237(2) 2015 (link)

Tahsin Kellici, Dimitrios Ntountaniotis, Eleni Vrontaki, George Liapakis, Panagiota Moutevelis-Minakakis, George Kokotos, Sotiris Hadjikakou, Andreas G. Tzakos, Antreas Afantitis, Georgia Melagraki, Sharon Bryant, Thierry Langer, Vincenzo Di Marzo, Thomas Mavromoustakos "Rational Drug Design Paradigms: The Odyssey for designing better Drugs"  Combinatorial Chemistry & HighThroughput Screening Volume 18 - Number 3 Pp: 238 - 256 2015 (link)

Vrontaki, E., Melagraki, G., Mavromoustakos, T., Afantitis, A. Exploiting ChEMBL database to identify indole analogs as HCV replication inhibitors Methods Volume 71, 1 January 2015, Pages 4–13 (link)

 
Afantitis, A. Editorial Combinatorial Chemistry & High Throughput Screening, 2014, Vol. 17, No. 5 395 2014 (link)

E. Vrontaki, G. Melagraki*, T. Mavromoustakos, A. Afantitis*. Searching for Anthranilic Αcid-Βased Thumb Pocket 2 HCV NS5B Polymerase Inhibitors through a Combination of Molecular Docking, 3D-QSAR and Virtual Screening Journal of Enzyme Inhibition and Medicinal Chemistry DOI:10.3109/14756366.2014.1003925 (link)

E. Vrontaki, G. Leonis, A. Avramopoulos, M. G. Papadopoulos, M. Simc ic, S. G. Grdadolnik, A. Afantitis, G. Melagraki, S. K. Hadjikakou, and T. Mavromoustakos. Stability and binding effects of silver(I) complexes at lipoxygenase-1 Journal of Enzyme Inhibition and Medicinal Chemistry 2015 30(4):539-49 (link)

Georgia Melagraki*, Antreas Afantitis*, Enalos InSilicoNano Platform: An online decision support tool for the design and virtual screening of nanoparticles  RSC Advances 2014, 4, 50713-50725 2014 (link)

Afantitis, A. Editorial (2013) Combinatorial Chemistry and High Throughput Screening, 16 (10), p. 763. (link)

Zhang, L., Sedykh, A., Tripathi, A., Zhu, H., Afantitis, A., Mouchlis, V.D., Melagraki, G., Rusyn, I., Tropsha, A. Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches (2013) Toxicology and Applied Pharmacology, 272 (1), pp. 67-76. (link), (Top 25 Hottest Articles July -September 2013)

Melagraki*, G., Afantitis*, A. “Enalos KNIME nodes: Exploring corrosion inhibition of steel in acidic medium” (2013) Chemometrics and Intelligent Laboratory Systems, 123, pp. 9-14. (link)

Agelis , G., Resvani, A., Koukoulitsa, C., Tůmová, T., Slaninová, J., Kalavrizioti, D., Spyridaki, K., Afantitis, A., Melagraki, G., Siafaka, A., Gkini, E., Megariotis, G., Grdadolnik, S.G., Papadopoulos, M.G., Vlahakos, D., Maragoudakis, M., Liapakis, G., Mavromoustakos, T., Matsoukas, J. Rational design, efficient syntheses and biological evaluation of N,N'-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers (2013) European Journal of Medicinal Chemistry, 62, pp. 352-370. (link)

Comparative Binding Effects of Aspirin and Anti-Inflammatory Cu Complex in the Active Site of LOX-1  E. Vrontaki, G. Leonis, M. G. Papadopoulos, M. Simcic, S. Golic Grdadolnik, A. Afantitis, G. Melagraki, S. K. Hadjikakou, and T. Mavromoustakos  J. Chem. Inf. Model., 2012, 52 (12), pp 3293–3301 (link)

Fotakis, C., Megariotis, G., Christodouleas, D., Kritsi, E., Zoumpoulakis, P., Ntountaniotis, D., Zervou, M., Potamitis, C., Hodzic, A., Pabst, G., Rappolt, M., Mali, G., Baldus, J., Glaubitz, C., Papadopoulos, M.G., Afantitis, A., Melagraki, G., Mavromoustakos, T. Comparative study of the AT 1 receptor prodrug antagonist candesartan cilexetil with other sartans on the interactions with membrane bilayers (2012) Biochimica et Biophysica Acta - Biomembranes, 1818 (12), pp. 3107-3120.(link)

Mouchlis Varnavas, Melagraki Georgia*, Mavromoustakos Thomas, Kollias George, Afantitis Antreas* "Molecular modeling on pyrimidine-urea inhibitors of TNF-α production: an integrated approach using a combination of molecular docking, classification techniques and 3D-QSAR CoMSIA" J. Chem. Inf. Model., 2012, 52 (3), pp 711–723 (link)

G. Melagraki* & A. Afantitis* Ligand and structure based virtual screening strategies for hit-finding and optimization of hepatitis C (HCV) inhibitors Curr. Med Chem. 2011 18(17) 2612-2619 (link)

A. Afantitis*, G. Melagraki*, P.A. Koutentis, H. Sarimveis, G. Kollias. Ligand - based virtual screening procedure for the prediction and the identification of novel β-amyloid aggregation inhibitors using Kohonen Maps and Counterpropagation Artificial Neural Networks, European Journal of Medicinal Chemistry 46 (2011) 497-508 (link)

Georgia Melagraki, Antreas Afantitis, Andrey A. Toropov, Haralambos Sarimveis and Olga Igglessi-Markopoulou "QSAR models constructed by optimal descriptors and by multiple regression analysis for the prediction of carbonic anhydrase II inhibitory activity of substituted aromatic sulfonamides"
Book Chapter: QSPR-QSAR Studies on Desired Properties for Drug Design ISBN 978-81-308-0404-0
     
G. Melagraki*,
Α. Afantitis,  H. Sarimveis, P.A. Koutentis, O. Igglessi – Markopoulou and G. Kollias "In Silico Exploration for Identifying Structure–Activity Relationship of MEK Inhibition  and Oral Bioavailability for Isothiazole Derivatives" Chemical Biology & Drug Design 2010; 76: 397–406 (link)

Α. Afantitis*, G. Melagraki,   H. Sarimveis, P.A. Koutentis, O. Igglessi – Markopoulou and G. Kollias*  "A combined LS-SVM & MLR QSAR workflow for predicting the inhibition of CXCR3 receptor by quinazolinone analogues"  Molecular Diversity (2010) 14:225-235 (link)

G. Melagraki*, A. Afantitis, H. Sarimveis, P. A. Koutentis, G. Kollias and O. Igglessi-Markopoulou "Predictive QSAR workflow for the in silico identification and screening of novel HDAC inhibitors"   2009 Molecular Diversity   Molecular Diversity 13 (3), pp. 301-311 (link)

Α. Afantitis*, G. Melagraki, H. Sarimveis, O. Igglessi – Markopoulou and G. Kollias* "A novel QSAR model for predicting the inhibition of CXCR3 receptor by 4-N-aryl-[1,4] diazepane ureas" European Journal of Medicinal Chemistry Volume 44, Issue 2, February 2009, Pages 877-884 (link)

Α. Afantitis*, G. Melagraki, H. Sarimveis, P.A.  Koutentis, J. Markopoulos and O. Igglessi – Markopoulou "Development and Evaluation of a QSPR Model or the Prediction of Diamagnetic Susceptibility" QSAR Comb. Sci. 27, 2008, No. 4, 432 – 436 (link)

G. Melagraki, Α. Afantitis, H. Sarimveis, P.A.  Koutentis, J. Markopoulos and  O. Igglessi –Markopoulou "Identification of a series of novel derivatives as potent HCV inhibitors by a ligand – based virtual screening optimized procedure" Bioorganic & Medicinal Chemistry 2007 15 7237-7147 (Top 25 Hottest Articles October - December 2007)  & (Top 25 Hottest Articles October - December 2008) (link)

G. Melagraki, Α. Afantitis, H. Sarimveis, P.A.  Koutentis, J. Markopoulos and  O. Igglessi –Markopoulou "Optimization of Biaryl Piperidine and 4-Amino-2-biarylurea MCH1 Receptor Antagonists using QSAR Modeling, Classification Techniques and Virtual Screening", Journal of Computer-Aided Molecular Design 2007 21 251-267. (link)

G. Melagraki, Α. Afantitis, H. Sarimveis, P.A.  Koutentis, J. Markopoulos and  O. Igglessi –Markopoulou "A novel QSPR model to predict θ (lower critical solution temperature) in polymer solutions using molecular descriptors" Journal of Molecular Modeling 2007 13 55-64 (link)

Α. Afantitis, G. Melagraki, H. Sarimveis, P.A.  Koutentis, J. Markopoulos and O. Igglessi – Markopoulou "A Novel QSAR Model for Modeling and Predicting Induction of Apoptosis by 4-Aryl-4H-chromenes". Bioorganic and Medicinal Chemistry 2006 14, 6686-6694 (link)

Α. Afantitis, G. Melagraki, H. Sarimveis, P.A.  Koutentis, J. Markopoulos and O. Igglessi – Markopoulou "Prediction of Intrinsic Viscosity in Polymer-Solvent Combinations using a QSPR model" Polymer 2006 47 3240-3248. (link)

Α. Afantitis, G. Melagraki, H. Sarimveis, P.A.  Koutentis, J. Markopoulos and  O. Igglessi –Markopoulou “A Novel QSAR Model for Evaluating and Predicting the Inhibition of Dipeptidyl Aspartyl Fluoromethylketones” QSAR & Combinatorial Science 2006 25 928-935 (link)

Α. Afantitis, G. Melagraki, H. Sarimveis, P.A.  Koutentis, J. Markopoulos and  O. Igglessi – Markopoulou “Investigation of  Substituent Effect of 1-(3,3-Diphenylpropyl) - Piperidinyl Phenylacetamides  Amides on CCR5 Binding Affinity using QSAR and Virtual Screening  Techniques” Journal of Computer-Aided  Molecular Design 2006 20, 83-95. Highlighted by Drug Discovery Today: Technologies, Volume 3, Issue 4, Winter 2006, Pages 405-411 Advances in virtual screening:  As recent success story (link)

G. Melagraki, Α. Αfantitis, H. Sarimveis, O. Igglessi –Markopoulou and C.T Supuran “QSAR study on para – substituted aromatic sulfonamides as carbonic anhydrase II inhibitors using topological information indices” Bioorganic and Medicinal Chemistry 2006 14 (4) 1108-1114. (link)  Most Cited Paper 2006-2009 Award (Pdf)

Α. Afantitis, G. Melagraki, H. Sarimveis, O. Igglessi –Markopoulou, J. Markopoulos and P.A.  Koutentis ‘A Novel Simple QSAR Model for the Prediction of anti-HIV Activity Using Multiple Linear Regression Analysis’ Molecular Diversity 2006 10, 405-414. (link)

 



 

web page
 hit
counter



Home
Who We Are
What We Do
R & D Projects
H2020-NMBP-2017
Products
Enalos KNIME Nodes
News@Twitter
Publications
Site Map
Contact Us

Copyright 2012. NovaMechanics Ltd, Nicosia, Cyprus. All rights reserved